BBIBP‐CorV – Sinopharm‐Beijing vs placebo
Serious adverse eventsk
BBIBP‐CorV – Sinopharm‐Beijing showed no clear difference in serious adverse eventsk compared with placebo (low certainty).
1 finding from 1 review
- RR 0.76 [0.54, 1.06]1 study · 26924 participantsLow